- With Mayo Clinic psychiatrist
David Mrazek, M.D.
read biographyclose windowBiography of
David Mrazek, M.D.
David Mrazek, M.D.
Dr. David A. Mrazek is chair of the Department of Psychiatry and Psychology at Mayo Clinic, Rochester, Minn., and a professor of psychiatry at College of Medicine, Mayo Clinic. Dr. Mrazek has developed a federally funded psychiatric pharmacogenomics research program and implemented clinical psychiatric pharmacogenomics services at Mayo Clinic.
He has received numerous awards including the Award for Creativity in Psychiatric Education from the American College of Psychiatrists and the Agnes Purcell McGavin Award for Distinguished Career Achievement in Child and Adolescent Psychiatry from the American Psychiatric Association. He currently serves as chairman of the board of the American Board of Psychiatry and Neurology.
Dr. Mrazek has focused his current efforts on using pharmacogenomics testing to improve clinical care. One of his specific goals is to decrease the risks of taking psychiatric medications.
Latest entries
- Complexity of depression diagnosis makes treatment difficult
March 8, 2012
- Depression sometimes shifts to bipolar disorder
Jan. 21, 2012
- Antidepressant use soaring among Americans 12 and over
Dec. 7, 2011
- Transcranial magnetic stimulation offers hope treating depression
Oct. 19, 2011
- New antidepressant offers hope
Sept. 3, 2011
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Depression blog
-
March 4, 2011
Access to gene testing for antidepressants improves
By David Mrazek, M.D.
Some of you have been interested in the recent discussion of pharmacogenetic testing and have asked if it's available. Yes, it's available, but many psychiatrists aren't yet comfortable with interpreting the results.
| Need more help? |
|
The Mayo Medical Laboratory began testing in 2003 to determine whether people could tolerate certain antidepressants. In a relatively short time, other large medical laboratories also began offering these tests.
Two things have happened to improve access to testing:
- First, a company called AssureRx Health was created to provide the results of these tests to psychiatrists using a more "physician friendly" report. A psychiatrist can now collect just a simple cheek swab sample of DNA, send it overnight to AssureRx and receive the results electronically within 36 to 48 hours.
- Second, more than 2,000 psychiatrists have taken a Mayo Clinic course designed to help them use this testing more efficiently.
By incorporating new research results from ongoing scientific studies, the testing is getting increasingly more accurate. While the results still can't provide a certain prediction of which antidepressant will be most effective, the tests do increase the chances of identifying an effective medication and can definitely identify medications that you're unlikely to be able to tolerate.
9 comments posted
Share on:
9 comments posted